Tyson Foods CapEx decreased by 42.5% to $145.00M in Q1 2026 compared to the prior quarter. Year-over-year, this metric declined by 24.9%, from $193.00M to $145.00M. Over 4 years (FY 2021 to FY 2025), CapEx shows a downward trend with a -5.2% CAGR.
An increase often signals growth initiatives and capacity expansion, while a decrease may suggest cost-cutting or a shift toward asset-light strategies.
This metric measures the cash outflows used to acquire, upgrade, and maintain physical assets such as property, building...
Commonly compared as a percentage of revenue; capital-intensive firms like Abbott require consistent investment to remain competitive in medical technology.
capital_expenditures| Q2 '21 | Q3 '21 | Q4 '21 | Q1 '22 | Q2 '22 | Q3 '22 | Q4 '22 | Q1 '23 | Q2 '23 | Q3 '23 | Q4 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | Q1 '26 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | $302.00M | $350.00M | $408.00M | $439.00M | $476.00M | $564.00M | $589.00M | $508.00M | $467.00M | $375.00M | $354.00M | $267.00M | $263.00M | $248.00M | $271.00M | $193.00M | $227.00M | $287.00M | $252.00M | $145.00M |
| QoQ Change | — | +15.9% | +16.6% | +7.6% | +8.4% | +18.5% | +4.4% | -13.8% | -8.1% | -19.7% | -5.6% | -24.6% | -1.5% | -5.7% | +9.3% | -28.8% | +17.6% | +26.4% | -12.2% | -42.5% |
| YoY Change | — | — | — | — | +57.6% | +61.1% | +44.4% | +15.7% | -1.9% | -33.5% | -39.9% | -47.4% | -43.7% | -33.9% | -23.4% | -27.7% | -13.7% | +15.7% | -7.0% | -24.9% |